New Covid vaccine Valneva approved for UK use 'may be more effective for longer'
A sixth coronavirus jab which may be more effective for longer has been approved for use in the UK by health officials. The Covid vaccine developed by Valneva was given regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA).
The UK is the first in the world to approve the vaccine. It has been approved for use in people aged 18 to 50 years, with the first and second doses to be taken at least 28 days apart.The jab developed by the French firm, which has a factory in Livingston near Edinburgh, is the sixth Covid-19 vaccine to be granted an MHRA authorisation.
According to the British Medical Journal, the vaccine could appeal to those who are more hesitant about taking current vaccines on offer as they use relatively new technology in their rollout.
With this type of vaccine, the virus is grown in a lab and then made completely inactive so that it cannot infect cells or replicate in the body but can still trigger an immune response to the virus.
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|